genomic factors influencing patient response to venetoclax-based regimens: analysis from cll13/gaia
Published 1 year ago • 121 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
1:36
the importance of genomic testing when making treatment decisions in cll
-
1:11
genomic testing can help identify patient risk factors and guide clinical decision-making
-
1:32
factors contributing to the pathogenesis of icaht
-
1:44
the genomics of rt and prognostic implications of rt characterization
-
5:36
mcl0208: identification of novel genomic prognostic factors
-
0:48
the importance of raising awareness about genomic testing in cll & existing and emerging biomarkers
-
1:45
integrating genomics into clinical hematology
-
1:28
genomic testing in cll
-
56:52
vicc vmtb 20241008
-
4:22
discover versiti diagnostic labs, clinical trials and biomaterials | versiti
-
28:55
blending biophysics and machine learning to predict the antibody response -tal einav, ph.d.
-
3:11
genetic mutations as poor prognostic indicators of hct in venetoclax-treated aml
-
1:01
practical considerations regarding genomic testing for molecular aberrations
-
3:43
genomic profiling to predict prognosis for patients with hr-smm
-
5:31
the role of venetoclax in older patients with aml
-
2:06
introducing molecular diagnostics to improve leukemia care in developing countries
-
4:32
acquired von willebrand disease in waldenström’s macroglobulinemia: diagnosis and treatment
-
3:20
car t-cells and bispecific antibodies in the treatment of double refractory cll
-
2:23
the importance of genomic testing in cll in the era of novel therapies
-
6:45
novel scoring system defines allo-hsct patients at high risk for cmv
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
0:48
building genetic assessments into how we determine prognosis of all